glp-1 bowel obstruction class action in kentucky Receptor Agonists Diabetes and Obesity: A Case Report and Review of Risks and Management Association of GLP-1 receptor agonists

GLP-1 receptor agonists are FDA-approved for multiple indications, primarily for type 2 diabetes management and weight loss, with semaglutide and liraglutide...

GLP-1s offer treatment for diabetes, obesity, heart disease and morebut there are caveats

What that looks like at two years, what dose-reduction options exist, and what

To report a case of non-arteritic ischemic optic neuropathy (NAION) in an otherwise healthy patient treated with Glucagon-Like Peptide-1 (GLP-1) receptor agonists (RAs) liraglutide and semaglutide

People are nuts about protein and likely beyond this claim, nobody cares what other nutritional attributes ...they're just "noise" (or a layered on health halo)